M
$ Value
$0
Shares
2,159
Price
$0
Filed
Jun 6
Insider
Name
YOUNGBLOOD DR KNEELAND
Title
—
CIK
0001137820
Roles
Director
Transaction Details
Transaction Date
2025-06-05
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
28,164
Footnotes
Represents the vesting of restricted stock units granted on June 5, 2024. The award has fully vested. Each restricted stock unit converted into a share of common stock on a one-for-one basis.
Filing Info
YOUNGBLOOD DR KNEELAND's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-10 | LNW | A | $0 |
| 2025-06-05 | LNW | M | $0 |
| 2025-06-05 | LNW | M | $0 |
Other Insiders at LNW (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Morro Stephen W | — | — | 2026-03-12 |
| Fine Capital Partners, L.P. | — | $1.7M | 2026-01-27 |
|
Wilson Matthew R.
President & CEO
|
— | — | 2026-03-20 |
| McLennan Hamish | — | $542K | 2026-03-12 |
|
Lane Siobhan
SVP & CEO - Gaming
|
— | $2.7M | 2026-03-20 |
|
Kalabic Vanja
SVP & Chief Accounting Officer
|
— | $137K | 2026-03-20 |
|
Chow Oliver
EVP, CFO & Treas
|
— | $464K | 2026-03-20 |